Dr. Delaram Safarpour, MD

Dr. Safarpour practices at OHSU Hospital in Portland, Oregon, part of State of Oregon.

Dr. Safarpour's NPI, 1285946533, was assigned on July 1, 2010. Dr. Safarpour holds Oregon license MD182558.

Dr. Safarpour's primary practice is OHSU Hospital, at 3181 SW Sam Jackson Park Road, Portland, OR 97239 in Multnomah County. The practice phone is (503) 494-9000.

Dr. Safarpour's primary practice is OHSU Hospital in Portland, Oregon, part of State of Oregon. Dr. Safarpour is also affiliated with Salem Hospital. The medical group on file is Oregon Health & Science University (OHSU). Dmand AI also links Dr. Safarpour to 1 more hospital, 1 clinical lab and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Safarpour practices, 5 sites in all. Vendor and product names are available with a free account.

Neurology is Dr. Safarpour's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dr. Safarpour is licensed in Oregon.

CMS data shows 242 Medicare services from Dr. Safarpour across 5 procedure codes in 2024, for 168 Medicare patients. Medicare paid $19,425 for them. Every service was in an office.

CMS counts 168 Medicare patients who saw Dr. Safarpour in 2024. The largest group is 65 to 74, with 71 patients. 70% of them have parkinson's disease, and 63% have high cholesterol. 13% are also on Medicaid. Their average risk score is 1.49, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Safarpour's median patient age at 74, with 46% women.

In 2024, Dr. Safarpour wrote 1,677 Medicare Part D claims for 213 patients. 88% of them were for generic drugs. CMS names the drug for 1,548 of them, across 31 drugs with 11 or more claims each, at $775,175 in total drug cost. In 2023, CMS named 1,552 claims across 27 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 99 out of 100 for Dr. Safarpour for performance year 2024, reported through an alternative payment model (APM). Dr. Safarpour accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Safarpour as offering telehealth.

Dmand AI links 26 papers to Dr. Safarpour, published from 2010 to 2025. 2023 was the busiest year, with 6. The most frequent topics are Parkinson Disease, Deep Brain Stimulation and Botulinum Toxins. Dr. Safarpour has published most often in Semin Neurol. Dr. Safarpour's most frequent co-authors are Bahman Jabbari, MD, Jocelyn Michelle Jiao, MD and Lauren Scott Talman, MD.

Dmand AI links Dr. Safarpour to 1 clinical trial. Conditions studied include Machado-Joseph Disease and Spinocerebellar Ataxias.

CMS Open Payments shows 142 general payments to Dr. Safarpour from 9 drug and device companies from 2017 to 2025. Speaker and faculty fees make up the largest share, 60% of the total. Boston Scientific Corporation paid the most, $57,752.